« Return to News | R&D Trends

Ascendancy Healthcare, Quintiles collaborate in China

Monday, July 29, 2013 01:30 PM

Ascendancy Healthcare, dedicated to the commercialization of therapeutic products to meet unmet medical needs in China and other high-growth Asian markets, has announced a multi-year collaboration with Quintiles, a provider of biopharmaceutical development and commercial outsourcing services.

Quintiles will provide product assessments and clinical research services including trial planning, productivity optimization and execution of cost-efficient studies for therapeutic compounds Ascendancy in-licenses for development and commercialization in China and other Asian markets.

The agreement will span a full spectrum of clinical development activities necessary for the registration of products for commercialization in China. The collaboration will be overseen by a joint development committee composed of representatives from both organizations. The two-and-a-half year agreement has an option for both organizations to renew for an additional two and a half years.

"This deal illustrates Quintiles' ability to provide customized solutions in China for customers anywhere in the world,” said Ling Zhen, general manager for Quintiles' operations in China. “By combining our expertise in product assessment from Quintiles' team in China and clinical trial services through our local CRO, Kun Tuo, we can fully support Ascendancy across the value chain, from strategy development to clinical execution to product approval and market access."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.